vancomycin: be used for mrsa

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.68
, antibiotic
Weight: 0.66
, medication
Weight: 0.61
, infection
Weight: 0.48
, compound
Weight: 0.42
Siblings ampicillin
Weight: 0.37
, metronidazole
Weight: 0.37
, warfarin
Weight: 0.36

Related properties

Property Similarity
be used for mrsa 1.00
be used treat 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.32
Plausible(vancomycin, be used for mrsa)
Evidence: 0.31
¬ Salient(vancomycin, be used for mrsa)

Similarity expansion

0.57
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.81
Evidence: 0.41
Typical(vancomycin, be used for mrsa)
Evidence: 0.31
¬ Typical(vancomycin, be used treat)
0.48
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.81
Evidence: 0.32
Plausible(vancomycin, be used for mrsa)
Evidence: 0.45
¬ Plausible(vancomycin, be used treat)
0.37
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.81
Evidence: 0.31
Salient(vancomycin, be used for mrsa)
Evidence: 0.66
¬ Salient(vancomycin, be used treat)
0.33
Rule weight: 0.85
Evidence weight: 0.47
Similarity weight: 0.81
Evidence: 0.39
Remarkable(vancomycin, be used for mrsa)
Evidence: 0.87
¬ Remarkable(vancomycin, be used treat)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.31
Salient(vancomycin, be used for mrsa)
Evidence: 0.41
¬ Typical(vancomycin, be used for mrsa)
Evidence: 0.39
¬ Remarkable(vancomycin, be used for mrsa)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.32
Plausible(vancomycin, be used for mrsa)
Evidence: 0.41
¬ Typical(vancomycin, be used for mrsa)